Requests similar to 'Provisional approval for COVID-19 vaccine' (page 2)

Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit

Follow up sent to Pharmaceutical Management Agency by Micky Turner on October 22, 2021.

Successful.

Hi Melody, Thanks for providing the information! Here is a summary of the details: Remdesivir is a failed Ebola drug. It was designed to treat E...

Benefits Outweigh Risks of Vaccination & Medications Causing 1 or More Deaths

Response by Ministry of Health to Jimmy Clarke on January 27, 2023.

Awaiting classification.

Kia ora Jimmy Please find attached a response to your request for official information. Ngā mihi OIA Services Team Manatū Hauora | Ministr...

Supply agreement with Pfizer for supply of Cominarty brand of Covid-19 vaccine

Response by Pharmaceutical Management Agency to John Armstrong on October 10, 2025.

Awaiting classification.

Kia ora John, Please find attached the response for your request for official information. Ngā mihi OIA Services Team Ministry of Healt...

Safety and efficacy of Pfizer Comirnaty

Response by Ministry of Health to Heather Darby on November 15, 2021.

Refused.

Kia ora Heather, Thank you for your emails. Your requests have been consolidated under section 18(A) of the Official Information Act 1982 (the A...

Pfizer Comirnaty Injections stop transmission

Response by Ministry of Health to Heather Darby on November 15, 2021.

Partially successful.

Kia ora Heather, Thank you for your emails. Your requests have been consolidated under section 18(A) of the Official Information Act 1982 (the A...

Questions over covid

Response by Ministry of Health to Athina Andonatou on April 14, 2021.

Partially successful.

Kia ora Please find attached a response to your official information act request Ngā mihi OIA Services Government Services Offic...

Risks Outweigh Benefits to Children

Response by Ministry of Health to Chris McCashin on October 28, 2021.

Long overdue.

Kia ora Chris Please find attached a letter regarding your request for information. Ngā mihi OIA Services Government Services Office of the Dir...

Fees paid to Medsafe by Pharmaceutical Industry

Response by Ministry of Health to Tracy Livingston on February 23, 2022.

Partially successful.

Kia ora Tracy Please find attached a response to your request for information Ngā mihi Ngā mihi OIA Services Team [1]Minist...

Reports on Pfizer vaccine failure and efficacy (from the provisional approval notice)

Request to Ministry of Health by Erika Whittome. Annotated by SPENCER JONES on October 06, 2025.

Awaiting response.

This Official Information Act (OIA) request (submitted October 5, 2025, ref: H2025073669) seeks reports mandated by Condition 54 of the Pfizer Comirnat...

Removal of Approved Drugs / Medicine

Response by Ministry of Health to Chris McCashin on February 17, 2023.

Awaiting classification.

Kia ora Chris, Please find attached the response for your request for official information. Ngā mihi OIA Services Team Manatū Hauora | Ministr...

Costs outweigh Benefits of Vaccine - Medsafe Disastrous Approval

Response by Ministry of Health to Chuck Schooner (Account suspended) on October 13, 2021.

Partially successful.

Kia ora Chuck, Thank you for your email. Please refer to the following links for information in response to your queries: o The status...

Purchase of Pfizer Comirnaty JN.1 and Comirnaty Omicron XBB.1.5

Response by Ministry of Health to John Armstrong on October 03, 2025.

Partially successful.

Kia ora John Please see attached a response to your request for official information. The Ministry apologises for the delay in responding to your req...

ALC-0315 correspondence

Response by Ministry of Health to Maxwell on October 29, 2021.

Successful.

Tçnâ koe Maxwell Thank you for your follow up request under the Official Information Act 1982 (the Act) to the Ministry of Health (the Ministry...

Medsafe Inconsistency

Response by Ministry of Health to Chuck Schooner (Account suspended) on April 07, 2022.

Awaiting classification.

Kia ora, Please find the attached that was sent to you 6 April 2022 at 2:15pm. Ngā mihi OIA Services Team [1]Ministry of Health informat...

NVX-CoV2373, Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine

Response by Ministry of Health to M.R.M. on November 03, 2021.

Long overdue.

Kia ora MRM, Please find attached a response to your official information act request Ngā mihi OIA Services Government Services...

The right to choose not to be immunised against Covid-19 - Part 2

Response by Ministry of Health to M.R.M. on November 03, 2021.

Long overdue.

Kia ora MRM, Please find attached a response to your official information act request Ngā mihi OIA Services Government Services...

Please explain the meaning of the Latest Regulatory Activity

Response by Ministry of Health to Virginia Crawford on October 14, 2021.

Long overdue.

Dear Virginia In answer to your OIA request, I have been asked to respond directly. In New Zealand Pre-marketing approval must be obtained for new an...

Medsafe Monitoring of Vaccine Side Effects

Response by Ministry of Health to Chuck Schooner (Account suspended) on March 25, 2022.

Partially successful.